|

SUL-238 (500 mg t.i.d.) film-coated tablets Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • GEN İlaç ve Sağlık Ürünleri A.Ş.1

Indications

  • Parkinson's Disease (PD)1
  • Parkinson's Disease1

Other1 trial

A Phase 2 Study to Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early, Untreated Parkinson's Disease
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.